Die neue Folge @pandemiapodcast ist da und wir hatten das Bedürfnis ausnahmsweise mal wieder über die Situation in Deutschland zu sprechen, übers Impfen, Testen und Lockern.
Episode ist hier und zur Begleitung ein kurzer Thread:
viertausendhertz.de/pan20/
@pandemiapodcast Wir haben uns ja bewusst entschieden mit dem Podcast quasi knapp an der Pandemie vorbei zu zielen und vor allem über andere Krankheiten und andere Orte zu sprechen. Weil dieser Kontext so wichtig ist und hilft, das Hier und Jetzt zu verstehen - und besser zu verarbeiten.
@pandemiapodcast Aber manchmal verlangt das Hier und Jetzt halt Aufmerksamkeit:
Wir sind am Anfang einer dritten Welle - mit Ansage.
Viele Forscher sind dementsprechend müde und desillusioniert. “Das ist frustrierend”, sagt @CorneliaBetsch. Andere Menschen, mit denen ich spreche, geht es genauso
@pandemiapodcast @CorneliaBetsch Als Politiker Anfang des Monats Lockerungen beschlossen, war das ein Schock. Wie @DirkBrockmann mir gesagt hat: “Ich dachte, ich höre nicht richtig.”
Tatsächlich war und ist die Entscheidung angesichts steigender Fallzahlen, der Verbreitung von #B117 etc. kaum nachvollziehbar.
@pandemiapodcast @CorneliaBetsch @DirkBrockmann Das Problem sind dabei nicht nur die Lockerungen selbst (die sind ja quasi schon Makulatur), sondern der Vertrauensverlust, den so eine kaum nachvollziehbare Entscheidung auslöst. Wir müssen alle noch ein wenig durchhalten und dafür war das politische Signal verheerend.
@pandemiapodcast @CorneliaBetsch @DirkBrockmann Wir wollten darum die Aufmerksamkeit noch einmal auf das Lenken, was jetzt nötig und möglich ist:
Weiter vorsichtig bleiben, Tests sinnvoll nutzen und impfen, impfen, impfen. So schnell wie möglich und so flexibel und pragmatisch wie nötig.
@pandemiapodcast @CorneliaBetsch @DirkBrockmann Vielen Dank noch an @florian_krammer und @hildabast, die mit uns über Impfstoffe und Studien gesprochen haben.
Und danke an alle, die uns hören und besonders diejenigen, die unsere Arbeit im Klub Pandemia unterstützen:
steadyhq.com/de/pandemia/ab…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Kai Kupferschmidt

Kai Kupferschmidt Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @kakape

22 Mar
“An estimated 1.4 million fewer people received care for TB in 2020, compared with 2019”, says @DrTedros at @WHO presser, noting that it’s #WorldTBDay tomorrow and that #covid19 has disrupted services. “We fear that more than half a million more people may have died. "
@DrTedros @WHO “In January, I said that the world was on the brink of a catastrophic moral failure unless urgent steps were taken to ensure equitable distribution of vaccines”, says @DrTedros. “We have the means to avert this failure. But it's shocking how little has been done to avert it.”
@DrTedros @WHO "Countries that are now vaccinating younger, healthy people at low risk of disease are doing so at the cost of the lives of health workers, older people, and other at risk groups, in other countries”, says @DrTedros.
Read 19 tweets
22 Mar
The first day of what will no doubt be a busy #covid19 week, started with some good news for AstraZeneca.
Results from the large trial in the Americas show AZ vaccine has 79% efficacy at preventing symptomatic #covid19.
Story here, few thoughts to come:
sciencemag.org/news/2021/03/a…
Caveat first:
Like most early vaccine results in this pandemic this is based solely on a press release by the company.
There are some big holes in what we know so far and I am getting pretty fed up with the dearth of data reported in these releases.
Companies need to do better.
The good news:
This was a well-designed trial with more than 32,000 participants and it shows strong protection from symptomatic #Covid19.
"I’m thrilled”, @ashishkjha told me. “This is the vaccine that I had always assumed would vaccinate a large chunk of the world.”
Read 9 tweets
21 Mar
For almost a whole year the number of #covid19 cases per 100,000 people was higher in the US than in Germany.
That changed this weekend: Image
Of course, there may be differences in how many infections were missed in each country at different time points and there were some days in winter when deaths per population were actually higher in Germany: Image
But the basic point is:
The US through naturally acquired immunity and through more than 120 million administered vaccine doses has reached a point where control has become easier.
The same is happening in Germany in coming months.
Read 5 tweets
18 Mar
"The committee has come to a clear scientific conclusion: This is a safe and effective vaccine. Its benefits in protecting people from #COVID19 with the associated risks of death and hospitalization outweigh the possible risks”, says Emer Cooke at @EMA_News press conference.
@EMA_News "The committee also concluded that the vaccine is not associated with an increase in the overall risk of thrombo embolic events or blood clots”, says Cooke.
@EMA_News "During the investigation and review we began to see a small number of cases of rare and unusual but very serious clotting disorders, and this then triggered a more focused review based on the evidence available”, says Cooke.
Read 17 tweets
18 Mar
EMA press conference on AstraZeneca safety signal is scheduled for 16.00 for now.

Just to give you an idea of what I will be looking out for, here are a few questions I would love to have answers to (and I don’t expect we can answer all of them already):
- Is there a significantly elevated number of people with the described clinical picture (widespread blood clotting, low platelet count, cerebral venous thrombosis) amongst vaccinees?
- Are there other things that unite them?
- Is there a common diagnosis? HUS, DIC, something?
- Is the age and gender distribution amongst cases unusual or in line with who was given the vaccine?
- Are most or all of the cases linked to a specific manufacturing plant?
- Any data on what treatments may have worked or not worked in these patients?
Read 4 tweets
17 Mar
A lot to say about AZ vaccine pause in Europe, but I will try to stick to a two key questions in this thread (more later):
1. What are the symptoms that have led to the pause?
2. Is there a plausible mechanism for the vaccine causing them?

Story is here: sciencemag.org/news/2021/03/i…
1. There has been a lot of general talk about blood clots and deep vein thrombosis, but the picture described to @GretchenVogel1 and me by doctors and regulatory agencies is a much more complicated one and based on at least 13 previously healthy individuals from 5 countries.
@GretchenVogel1 Main characteristics seem to be:
- widespread blood clots
- few platelets (thrombocytopenia)
- internal bleeding
- cerebral venous thrombosis

As @steinarma told us: “It’s a very special picture”.
Read 16 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!